JMP Securities Initiates Impax Laboratories With Outperform

Analysts at JMP Securities initiated coverage on Impax Laboratories

with a Outperform rating. The target price for Impax Laboratories is set to $38. Impax Laboratories shares have jumped 31.18% over the past 52 weeks, while the S&P 500 index has gained 10.64% in the same period. Impax Laboratories' shares fell 1.50% to close at $27.01 yesterday.